Skip to main content

Table 2 Antibody panels for mIHC

From: Aspartate-β-hydroxylase and hypoxia marker expression in head and neck carcinomas: implications for HPV-associated tumors

Panel

#

Primary antibody (dilution, incubation)

AR buffer (incubation)

Secondary antibody

OPAL (dilution)

A

1

VEGFA (1:150, OVN/4°C)

AR9 (30 min)

Opal Polymer HRP Ms + Rb

540 (1:200)

2

HIF1A (1:200, 1 h/RT)

AR6 (60 min)

520 (1:100)

3

ASPH (1:1200, OVN/4°C)

AR6 (15 min)

620 (1:100)

4

Cytokeratin (1:1000, 1 h/RT)

AR6 (15 min)

690 (1:200)

5

DAPI (1:15, 5 min/RT)

   

B

1

MMP13 (1:200, OVN/4°C)

AR9 (30 min)

Opal Polymer HRP Ms + Rb

650 (1:150)

2

GLUT1 (1:600, 1 h/RT)

AR9 (15 min)

520 (1:150)

3

MMP9 (1:900, OVN/4°C)

AR9 (25 min)

570 (1:150)

4

Cytokeratin (1:1000, 1 h/RT)

AR6 (30 min)

690 (1:200)

5

DAPI (1:15, 5 min/RT)

   
  1. AR - antigen retrieval buffer; HRP - horseradish peroxidase, OVN - overnight, RT - room temperature